Despite the industry’s best efforts to control colibacillosis in layers, broilers and breeders, the bacterial disease caused by avian pathogenic Escherichia coli (APEC) continues to challenge producers and researchers.
Ancera has released a new suite of comprehensive monitoring tools to provide allied companies of the poultry industry with real-time, third-party evidence demonstrating product efficacy.
Developing a recombinant vaccine that protects against infectious bursal disease plus two other viral bugs – infectious laryngotracheitis and Marek’s disease – may sound simple on paper. But in the world of vaccine development, 1 + 1 doesn’t necessarily equal 2.
Most poultry producers today use vaccines to help manage coccidiosis. Live coccidial vaccines are designed to uniformly infect birds with a controlled number of Eimeria oocysts to stimulate a protective immune response, but not all vaccines are the same.
Veterinary data play a critical role in not only analyzing poultry health but also implementing long- and short-term strategies to improve health and prevent disease. However, several challenges present roadblocks to capturing and interpreting these data.
Poultry farms seeking protection against infectious laryngotracheitis (ILT) outbreaks may find the best defense for layers and broiler-breeder replacement birds is a dual ILT vaccination program.
As poultry companies continue to increase their oversight of products in response to tightening margins, suppliers are under greater pressure to provide third-party data demonstrating product efficacy.
Prolonged exposure to heat stress can lead to respiratory injury in broiler chickens, according to a recent study in China.
Using the antibiotic bacitracin in poultry poses virtually no risk of an untreatable human infection from antimicrobial-resistant bacteria originating from chicken and turkey products, reports Randall Singer, DVM, PhD, University of Minnesota.
A multistate salmonella outbreak in the US due to the consumption of contaminated turkey products spurred a joint effort between the Centers for Disease Control and the turkey industry to identify an untraditional serotype of Salmonella, S. enterica serotype Reading (S. Reading).
USDA’s Center for Veterinary Biologics has granted Huvepharma a conditional license for the manufacturing and sale of a new turkey coccidiosis vaccine.
Merck Animal Health has introduced FLOCKSECURE™ poultry health portal, an innovative web-based platform solution designed to capture, maintain, distribute and analyze data from post-mortem sessions.
Copyright ©Feeks Media LLC, 2024 | All rights reserved
info@modernpoultry.media
privacy policy | site map
